Abstract
Insulin resistance (IR) is a condition in which target cells become insensitive
to normal insulin concentrations in order to deliver glucose. The goal of this
study was to see if solasodine combined with coenzyme Q10 could help rats with
insulin resistance caused by a high-fat diet (HFD) by regulating the expression
of IRS-I and PPAR-γ proteins.One of the six groups (n=6) got a
conventional diet for 16 weeks as a control (normal), the HFD was given to the
other five groups for 16 weeks, which further classified as-one group as HFD
control while others treated with pioglitazone (10 mg/kg),
coenzyme Q10 (50 mg/kg), solasodine (50 mg/kg)
and combination of solasodine and coenzyme Q10i.e. SDQ10 (total
50 mg/kg) for the last 4 weeks orally once daily. Blood and
tissue samples were collected by the end of study period for the biochemical and
histological studies. As a result, HFD fed rats exhibited a significant increase
in food and energy intake, body mass index, kidney and pancreas weight, fasting
glucose, glycosylated haemoglobin, insulin level, liver enzyme ALT and AST and
decrease antioxidant activity of superoxide dismutase and catalase. HFD received
animals also produced a lower level of p-IRS1 and PPAR-y protein expression in
western blot analysis. SDQ10 in combination successfully restored the
above-mentioned complexity of insulin resistance caused by aHFD. Besides,
increasesthe antioxidant activity of superoxide dismutase and catalase and
normalized the architecture of kidney, pancreas and adipose tissue as well
astreatment with SDQ10 raised the level of p-IRS1 and PPAR-y protein in liver
tissue. As a result, supplementing with solasodine and coenzyme Q10 reversed the
effect of the HFD on p-IRS1 and PPAR-y protein in liver tissue while also
alleviating insulin resistance symptoms.
Key words
Insulin resistance - p-IRS1 - PPAR-y - Antioxidant - Western blot - Glycosylated haemoglobin.